Cypress Capital’s Nu Skin NUS Stock Holding History

Cypress Capital’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,522	Closed	-$456K	–	154
2022 Q2	$456K	Hold	10,522	–	–	0.07%	135
2022 Q1	$504K	Hold	10,522	–	–	0.06%	146
2021 Q4	$534K	Hold	10,522	–	–	0.06%	144
2021 Q3	$426K	Buy	10,522 +10,517	+210,340%	+$532K	0.05%	141
2021 Q2	$0	Hold	5	–	–	﹤0.01%	101
2021 Q1	$0	Buy	+5	New	+$272	﹤0.01%	118

Other funds holding NUS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Cypress Capital's NUS Position: Q3 2022 in Review

Cypress Capital sold out of Nu Skin (NUS) in Q3 2022, closing a stake of 10,522 shares — an estimated $456K sold.

Cypress Capital first reported a position in NUS in Q1 2021 and held it in 6 quarters. The position peaked at $534K in Q4 2021. 207 funds tracked by Wall St. Rank hold NUS as of Q3 2022.

Cypress Capital reported no remaining Nu Skin position as of Q3 2022 after selling out during the quarter.
Cypress Capital sold 10,522 Nu Skin shares in Q3 2022, an estimated $456K.
Cypress Capital first reported a position in Nu Skin in Q1 2021 and held it in 6 quarters.
Cypress Capital's Nu Skin position peaked at $534K in Q4 2021.
207 funds tracked by Wall St. Rank held Nu Skin as of Q3 2022.

Based on Cypress Capital's 13F filing for Q3 2022, filed 1 Feb 2023.